Evidence map›Paper›PMID 41676207›Full record

ArticleAME case reports2026

Spontaneous pneumothorax in a patient with tuberculosis-induced destroyed lung successfully treated with autologous blood and minocycline pleurodesis: a case report.

Eitetsu Koh, Yasuo Sekine

Erratum issuedAbstract readCase Reports
In one paragraph

Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Eitetsu KohDepartment of Thoracic Surgery, Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Chiba, Japan.
Yasuo SekineDepartment of Respiratory Medicine, Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Chiba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Spontaneous pneumothorax in a tuberculosis-induced destroyed lung is uncommon and challenging, particularly when surgery poses prohibitive risk. Practical, non-surgical strategies that reliably control persistent air leak are therefore needed. Case Description: A 48-year-old woman with prior pulmonary tuberculosis and a destroyed right lung presented with right-sided pneumothorax. On arrival, she maintained adequate oxygenation on room air and did not require supplemental oxygen. Despite appropriate chest drainage, a persistent air leak continued for more than 2 weeks. Chemical pleurodesis was performed via the chest tube using a combined regimen of minocycline 100 mg diluted in 50 mL normal saline plus 50 mL autologous blood (total instilled volume 100 mL). Because leakage persisted, a second pleurodesis with the same regimen was performed 48 hours later. Within 24 hours after the second procedure, the air leak ceased. Follow-up chest radiography confirmed re-expansion, the chest tube was removed on day 21, and the patient was discharged without complications. Outpatient follow-up at approximately 2 weeks, 1 month, and 3 months included chest radiographs at the first two visits; no recurrence was observed, and the patient reported satisfactory daily activity without dyspnea beyond baseline. Conclusions: In high-risk patients with post-tuberculosis destroyed lung and persistent air leak, combined autologous blood and minocycline pleurodesis can provide effective, bedside control and avert surgery. This case details a simple two-step protocol with explicit dosing and timing that may be considered when operative management is unsuitable.

Indexed as

autologous bloodcase reportdestroyed lungminocyclineSpontaneous pneumothorax

Identifiers

PMID41676207
PMCPMC12885775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.